Reviewed by Peptide Treatments Medical Advisory Board
Pinealon: Research & Evidence
Early-Stage ResearchPublished research, clinical trial data, and evidence grading for Pinealon across studied indications.
Back to Pinealon overviewResearch Summary
Pinealon has zero PubMed-indexed human studies, zero RCTs, and no Western clinical trials. All efficacy claims derive from Russian-language animal studies that have not been independently replicated. The fundamental question of blood-brain barrier penetration for a 461 Da tripeptide remains unanswered.
Evidence by Indication (2 indications)
| Indication | Tier | Trials | Summary |
|---|---|---|---|
| Cognitive enhancement | Tier D | 0 | No human trials exist; rodent maze studies reported from Russian sources remain unverified |
| Neuroprotection | Tier D | 0 | Animal data suggests neuron survival benefits but no human translation has been attempted |
Graded using our evidence tier methodology.
Research Gap Score /10
Higher score = larger gap between therapeutic potential and available clinical evidence.